IVZ vs MS

For growth investors, Morgan Stanley (MS) is the stronger pick with 16.

8% revenue growth year-over-year, versus 5. 1% for Invesco Ltd. (IVZ). Morgan Stanley (MS) offers the better valuation at 24. 3x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Invesco Ltd.

is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.

2%, compared to +10. 6% for Invesco Ltd. (IVZ). Over 10 years, the gap is even starker: MS returned +739. 4% versus IVZ's +23. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Morgan Stanley (MS) is the lower-risk stock at 1.

37β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 22% more volatile than MS relative to the S&P 500. On balance sheet safety, Invesco Ltd. (IVZ) carries a lower debt/equity ratio of 78% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.

8% versus 5. 1% for Invesco Ltd. (IVZ). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Invesco Ltd.

(IVZ) trades at 10. 6x forward P/E versus 16. 3x for Morgan Stanley — 5. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IVZ: 8. 7% to $29. 72.

All stocks in this comparison pay dividends.

Invesco Ltd. (IVZ) offers the highest yield at 3. 0%, versus 2. 0% for Morgan Stanley (MS).

For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2.

0% yield, +739. 4% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MS: +739. 4%, IVZ: +23. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IVZ is a mid-cap income-oriented stock; MS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.